Facebook Pixel Code

Accretion Pharmaceuticals Share Price

NSE
BSE

ACCRETION PHARMACEUTICALS

Sector : Pharmaceuticals and health care | Smallcap | NSE

Here's the live share price of Accretion Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹62.50
-0.79₹ -0.5
As on Sep 5, 2025, 12:26 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Accretion Pharmaceuticals Price Performance

Today's LowToday's High
₹62.50₹62.50
₹62.50
52 Weeks' Low52 Weeks' High
₹57.40₹82.95
₹62.50
Open Price
₹62.50
Prev. Close
₹63.00
Volume
1,200

Over the last 5 years, the share price of Accretion Pharmaceuticals has declined 5.50% CAGR. Over the past year, the corresponding return has been -24.65%.

Accretion Pharmaceuticals’s current P/E of 0.00x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Accretion Pharmaceuticals Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Accretion Pharmaceuticals
3.735.4-2.5-24.65-24.65-9-5.5
Sun Pharmaceutical Industries
-0.63-2.92-5.860.12-13.2521.4425.29
Divi's Laboratories
-1.88-6.12-9.239.0617.4918.7513.47
Cipla
-2.13.754.449.6-4.4114.916.77
Torrent Pharmaceuticals
0.16-0.6613.4919.73.5732.8520.71
Mankind Pharma
3.28-2.548.1911.553.221.5212.41
Dr. Reddy's Laboratories
-0.013.72-2.3711.86-5.9114.347.35
Zydus Lifesciences
2.634.865.3613.46-9.7139.4622.14
Lupin
2.083.75-3.05-3.77-15.5443.6115.89
Abbott India
-1.16-6.44-1.83-1.064.8919.5513.55
Alkem Laboratories
-0.257.59.2212.64-15.7220.3513.41
Aurobindo Pharma
1-3.81-10.46-5.01-32.324.385.51
Glenmark Pharmaceuticals
6.5-0.1829.2847.6219.8676.6934.45
Biocon
3.56-3.129.1211.05-5.777.2-3.09
Laurus Labs
2.652.5837.3155.2879.8916.0529.68
GlaxoSmithKline Pharmaceuticals
0.28-1.28-19.433.69-0.7624.711.43
Anthem Biosciences
1.9113.1614.1414.1414.144.512.68
Cohance Lifesciences
3.07-5.62-14.68-22.75-21.1522.5421.92
Ipca Laboratories
-3.58-6.45-3.69-2.19-7.5714.635.49
Ajanta Pharma
5.72-0.621.612.24-21.3424.8420.82

Over the last one year, Accretion Pharmaceuticals has declined 24.65% compared to peers like Sun Pharmaceutical Industries (-13.25%), Divi's Laboratories (17.49%), Cipla (-4.41%). From a 5 year perspective, Accretion Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (25.29%) and Divi's Laboratories (13.47%).

Accretion Pharmaceuticals Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Accretion Pharmaceuticals Stock Technicals

Moving Average

DaySMAEMA
560.8661.92
1060.0861.1
2060.0961.04
5063.9863.86
10047.810
20023.90

Accretion Pharmaceuticals Share Holding Pattern

In the latest quarter, Accretion Pharmaceuticals remained same as its previous close in promoter holding, while DII stake decreased to 0.09%, FII holding fell to 2.22%, and public shareholding moved up to 24.19% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Accretion Pharmaceuticals Corporate Actions

There's no recent Announcement information to show for the company. You may visit the Accretion Pharmaceuticals fact sheet for more information

About Accretion Pharmaceuticals

Accretion Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 18/12/2012 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U21004GJ2023PLC146545 and registration number is 146545. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 57.38 Cr. and Equity Capital is Rs. 8.17 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Vivek Ashok Kumar Patel
    Managing Director
  • Mr. Mayur Popatlal Sojitra
    Director
  • Mr. Harshad Nanubhai Rathod
    Director & CEO
  • Mr. Hardik Mukundbhai Prajapati
    Director
  • Mr. Chand Rameshbhai Kanabar
    Independent Director
  • Mr. Vijay Bharatbhai Anadkat
    Independent Director
  • Ms. Grishma A Shewale
    Independent Director

FAQs on Accretion Pharmaceuticals Share Price

What is the share price of Accretion Pharmaceuticals?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Accretion Pharmaceuticals is ₹62.50 as on Sep 05, 2025.

What kind of stock is Accretion Pharmaceuticals?

The Accretion Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.

What is the Market Cap of Accretion Pharmaceuticals?

The market cap of Accretion Pharmaceuticals is ₹69.47 Cr as on Sep 05, 2025.

What are today's High and Low prices of Accretion Pharmaceuticals?

Today’s highest and lowest price of Accretion Pharmaceuticals are ₹62.50 and ₹62.50.

What are the 52 Week High and 52 Week Low of Accretion Pharmaceuticals?

The 52-week high/low is the highest and lowest price at which Accretion Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Accretion Pharmaceuticals is ₹82.95 and 52-week low of Accretion Pharmaceuticals is ₹57.40 as on Sep 05, 2025.

How has the Accretion Pharmaceuticals performed historically in terms of returns?

The Accretion Pharmaceuticals has shown returns of -0.79% over the past day, 5.4% for the past month, -2.5% over 3 months, -24.65% over 1 year, -9.0% across 3 years, and -5.5% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Accretion Pharmaceuticals?

P/E ratio of and PB ratio of Accretion Pharmaceuticals are 0.00 and 4.20 on Sep 05, 2025. While the company gives a dividend yield of 0.00 per annum.

icon
Market Data